Article
EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation.
Targeted oncology - 1 Mar 2024
Zhao Ruiying, Li Jiaqi, Guo Lianying, Xiang Chan, Chen Shengnan, Zhao Jikai, Shao Jinchen, Zhu Lei, Ye Min, Qin Gang, Chu Tianqing, Han Yuchen
Abstract excerpt
BACKGROUND: Data from studies looking at both EGFR and ERBB2 exon 20 insertion mutations (-20ins) in the same cohort of patients with non-small cell lung cancer (NSCLC) are limited. OBJECTIVE: The purpose of this study was to analyze EGFR/ERBB2-20ins in all-stage NSCLC patients to reveal their histological and molecular features, and to retrospectively evaluate the results of first-line real-world systemic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.